|
Volumn 29, Issue 1-2, 1997, Pages 48-50
|
Sirolimus: A new agent for clinical renal transplantation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOSPORIN A;
CYTOKINE RECEPTOR;
IMMUNOGLOBULIN A;
IMMUNOGLOBULIN G;
IMMUNOGLOBULIN M;
INTERLEUKIN 2;
INTERLEUKIN 3;
INTERLEUKIN 5;
INTERLEUKIN 6;
PHOSPHATIDYLINOSITOL KINASE;
RAPAMYCIN;
TACROLIMUS;
XENOBIOTIC AGENT;
B LYMPHOCYTE;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG MECHANISM;
DRUG POTENTIATION;
GRAFT REJECTION;
HUMAN;
HYPERLIPIDEMIA;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY TRANSPLANTATION;
NEPHROTOXICITY;
NEUROTOXICITY;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN PHOSPHORYLATION;
SIGNAL TRANSDUCTION;
T LYMPHOCYTE;
THROMBOCYTOPENIA;
ANIMALS;
CYCLOSPORINE;
DRUG SYNERGISM;
DRUG THERAPY, COMBINATION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
POLYENES;
SIROLIMUS;
T-LYMPHOCYTES;
|
EID: 0030905014
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(96)00008-5 Document Type: Conference Paper |
Times cited : (83)
|
References (23)
|